Advertisement

Topics

Aptinyx Initiates Phase II Clinical Studies Evaluating NYX-2925 In Two Chronic Pain Conditions

20:00 EDT 31 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Aptinyx Initiates Phase II Clinical Studies Evaluating NYX-2925 In Two Chronic Pain Conditions

NEXT ARTICLE

More From BioPortfolio on "Aptinyx Initiates Phase II Clinical Studies Evaluating NYX-2925 In Two Chronic Pain Conditions"

Quick Search
Advertisement